(Q68832548)
Statements
An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice (English)
M Mihara
T Nakano
1 December 1987
scientific article published on 01 December 1987